{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:23:17Z","timestamp":1778548997255,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Michael Mosier Defeat DIPG Foundation"},{"DOI":"10.13039\/100010612","name":"ChadTough Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010612","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Seattle Run of Hope"},{"name":"Unravel Pediatric Cancer"},{"name":"Brain Tumor Research Fund Guild of Seattle Children's Hospital"},{"name":"McKenna Claire Foundation"},{"name":"Team Cozzi Foundation"},{"name":"Grousemont Foundation"},{"name":"The Julianna Sayler Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11060-020-03558-w","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T09:02:46Z","timestamp":1592384566000},"page":"607-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children\u2019s Hospital experience"],"prefix":"10.1007","volume":"148","author":[{"given":"Erin E.","family":"Crotty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E. S.","family":"Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Russell","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan E.","family":"Millard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee A.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph P.","family":"Ermoian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie L.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M.","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera A.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel R.","family":"Browd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Ellenbogen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason S.","family":"Hauptman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey G.","family":"Ojemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3966-4985","authenticated-orcid":false,"given":"Nicholas A.","family":"Vitanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"issue":"4","key":"3558_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR, Bjerke L, Clarke M, Vinci M, Nandhabalan M, Temelso S, Popov S, Molinari V, Raman P, Waanders AJ, Han HJ, Gupta S, Marshall L, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Ng H-K, Li X, Mu K, Trabelsi S, Brahim DHM-B, Kisljakov AN, Konovalov DM, Moore AS, Carcaboso AM, Sunol M, De Torres C, Cruz O, Mora J, Shats LI, Stavale JN, Bidinotto LT, Reis RM, Entz-Werle N, Farrell M, Cryan J, Crimmins D, Caird J, Pears J, Monje M, Debily M-A, Castel D, Grill J, Hawkins C, Nikbakht H, Jabado N, Baker SJ, Pfister SM, Jones DTW, Fouladi M, Von Bueren AO, Baudis M, Resnick A, Jones C (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(4):520\u2013537.e525. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"issue":"9","key":"3558_CR2","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","volume":"19","author":"T Cooney","year":"2017","unstructured":"Cooney T, Lane A, Bartels U, Bouffet E, Goldman S, Leary SES, Foreman NK, Packer RJ, Broniscer A, Minturn JE, Shih C-S, Chintagumpala M, Hassall T, Gottardo NG, Dholaria H, Hoffman L, Chaney B, Baugh J, Doughman R, Leach JL, Jones BV, Fouladi M, Warren KE, Monje M (2017) Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study. Neuro-Oncology 19(9):1279\u20131280. https:\/\/doi.org\/10.1093\/neuonc\/nox107","journal-title":"Neuro-Oncology"},{"issue":"6","key":"3558_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"suppl_4","key":"3558_CR4","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro-Oncology 20(suppl_4):iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro-Oncology"},{"key":"3558_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","volume":"73","author":"GO Janssens","year":"2017","unstructured":"Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, Van Beek K, Benghiat H, Hoeben B, Morales La Madrid A, Kortmann R-D, Hargrave D, Menten J, Pecori E, Biassoni V, Von Bueren AO, Van Vuurden DG, Massimino M, Sturm D, Peters M, Kramm CM (2017) Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group. Eur J Cancer 73:38\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.007","journal-title":"Eur J Cancer"},{"issue":"5","key":"3558_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00381-019-04118-y","volume":"35","author":"VM Lu","year":"2019","unstructured":"Lu VM, Welby JP, Mahajan A, Laack NN, Daniels DJ (2019) Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis. Child's Nerv Syst 35(5):739\u2013746. https:\/\/doi.org\/10.1007\/s00381-019-04118-y","journal-title":"Child's Nerv Syst"},{"issue":"3","key":"3558_CR7","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ijrobp.2017.07.026","volume":"99","author":"AD Rao","year":"2017","unstructured":"Rao AD, Rashid AS, Chen Q, Villar RC, Kobyzeva D, Nilsson K, Dieckmann K, Nechesnyuk A, Ermoian R, Alcorn S, MacDonald SM, Ladra MM, Ford EC, Winey BA, Figueiredo MLS, Chen MJ, Terezakis SA (2017) Reirradiation for recurrent pediatric central nervous system malignancies: a multi-institutional review. Int J Radiat Oncol Biol Phys 99(3):634\u2013641. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3558_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27881","author":"DS Tsang","year":"2019","unstructured":"Tsang DS, Oliveira C, Bouffet E, Hawkins C, Ramaswamy V, Yee R, Tabori U, Bartels U, Huang A, Millar BA, Crooks B, Bowes L, Zelcer S, Laperriere N (2019) Repeat irradiation for children with supratentorial high-grade glioma. Pediatr Blood Cancer. https:\/\/doi.org\/10.1002\/pbc.27881","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"3558_CR9","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/cncr.21534","volume":"104","author":"V Bernier-Chastagner","year":"2005","unstructured":"Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, Luporsi E, Margueritte G, Lejars O, Laithier V, Mechinaud F, Millot F, Kalifa C, Chastagner P (2005) Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas. Cancer 104(12):2792\u20132797. https:\/\/doi.org\/10.1002\/cncr.21534","journal-title":"Cancer"},{"issue":"2","key":"3558_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1158\/1078-0432.ccr-08-1923","volume":"15","author":"A Broniscer","year":"2009","unstructured":"Broniscer A, Baker SJ, Stewart CF, Merchant TE, Laningham FH, Schaiquevich P, Kocak M, Morris EB, Endersby R, Ellison DW, Gajjar A (2009) Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. Clin Cancer Res 15(2):701\u2013707. https:\/\/doi.org\/10.1158\/1078-0432.ccr-08-1923","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3558_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","volume":"106","author":"A Chassot","year":"2012","unstructured":"Chassot A, Canale S, Varlet P, Puget S, Roujeau T, Negretti L, Dhermain F, Rialland X, Raquin MA, Grill J, Dufour C (2012) Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol 106(2):399\u2013407. https:\/\/doi.org\/10.1007\/s11060-011-0681-7","journal-title":"J Neurooncol"},{"issue":"11","key":"3558_CR12","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/cncr.23078","volume":"110","author":"M Fouladi","year":"2007","unstructured":"Fouladi M, Nicholson HS, Zhou T, Laningham F, Helton KJ, Holmes E, Cohen K, Speights RA, Wright J, Pollack IF (2007) A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma\/primitive neuroectodermal tumor, or brainstem glioma: a children's oncology group study. Cancer 110(11):2535\u20132541. https:\/\/doi.org\/10.1002\/cncr.23078","journal-title":"Cancer"},{"issue":"6","key":"3558_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/neuonc\/nos315","volume":"15","author":"LB Kilburn","year":"2013","unstructured":"Kilburn LB, Kocak M, Schaedeli Stark F, Meneses-Lorente G, Brownstein C, Hussain S, Chintagumpala M, Thompson PA, Gururangan S, Banerjee A, Paulino AC, Kun L, Boyett JM, Blaney SM (2013) Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro-Oncology 15(6):759\u2013766. https:\/\/doi.org\/10.1093\/neuonc\/nos315","journal-title":"Neuro-Oncology"},{"issue":"2","key":"3558_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/pbc.21154","volume":"50","author":"DN Korones","year":"2008","unstructured":"Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C (2008) Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study. Pediatr Blood Cancer 50(2):227\u2013230. https:\/\/doi.org\/10.1002\/pbc.21154","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"3558_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1215\/15228517-2006-031","volume":"9","author":"IF Pollack","year":"2007","unstructured":"Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM (2007) Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report1. Neuro-Oncology 9(2):145\u2013160. https:\/\/doi.org\/10.1215\/15228517-2006-031","journal-title":"Neuro-Oncology"},{"issue":"1","key":"3558_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11060-006-9251-9","volume":"82","author":"CD Turner","year":"2007","unstructured":"Turner CD, Chi S, Marcus KJ, Macdonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW (2007) Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol 82(1):95\u2013101. https:\/\/doi.org\/10.1007\/s11060-006-9251-9","journal-title":"J Neurooncol"},{"issue":"1","key":"3558_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2015.03.019","volume":"53","author":"BH Cohen","year":"2015","unstructured":"Cohen BH, Geyer JR, Miller DC, Curran JG, Zhou T, Holmes E, Ingles SA, Dunkel IJ, Hilden J, Packer RJ, Pollack IF, Gajjar A, Finlay JL (2015) Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 phase I\/II study. A report from the Children's Oncology Group. Pediatr Neurol 53(1):31\u201346. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.03.019","journal-title":"Pediatr Neurol"},{"key":"3558_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/bf00250203","author":"P Duffner","year":"1996","unstructured":"Duffner P, Krischer J, Burger P, Cohen M, Backstrom J, Horowitz M, Sanford R, Friedman H, Kun L (1996) Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience. J Neuro-Oncol. https:\/\/doi.org\/10.1007\/bf00250203","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"3558_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/neuonc\/noq205","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, Pollack IF (2011) Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro-Oncology 13(4):410\u2013416. https:\/\/doi.org\/10.1093\/neuonc\/noq205","journal-title":"Neuro-Oncology"},{"issue":"3","key":"3558_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/neuonc\/noq191","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, Brat DJ, Rosenblum MK, Hamilton RL, Lavey RS, Heideman RL (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro-Oncology 13(3):317\u2013323. https:\/\/doi.org\/10.1093\/neuonc\/noq191","journal-title":"Neuro-Oncology"},{"key":"3558_CR21","doi-asserted-by":"publisher","DOI":"10.1200\/jco.1995.13.1.112","author":"L Jonathan","year":"1995","unstructured":"Jonathan L, Finlay JMB, Yates AJ, Wisoff JH, Milstein JM, Russell Geyer J, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, Turski PA, Wara WM, Edwards M, Sutton LN, Berger MS, Epstein F, Ayers G, Allen JC, Packer RJ (1995) Randomized phase iii trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-l-day regimen. J Clin Oncol. https:\/\/doi.org\/10.1200\/jco.1995.13.1.112","journal-title":"J Clin Oncol"},{"issue":"11","key":"3558_CR22","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1634\/theoncologist.2009-0121","volume":"14","author":"MH Cohen","year":"2009","unstructured":"Cohen MH, Shen YL, Keegan P, Pazdur R (2009) FDA drug approval summary: bevacizumab (Avastin(R)) as treatment of recurrent glioblastoma multiforme. Oncologist 14(11):1131\u20131138. https:\/\/doi.org\/10.1634\/theoncologist.2009-0121","journal-title":"Oncologist"},{"issue":"3","key":"3558_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11060-010-0444-x","volume":"103","author":"C Parekh","year":"2011","unstructured":"Parekh C, Jubran R, Erdreich-Epstein A, Panigrahy A, Bluml S, Finlay J, Dhall G (2011) Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen. J Neurooncol 103(3):673\u2013680. https:\/\/doi.org\/10.1007\/s11060-010-0444-x","journal-title":"J Neurooncol"},{"issue":"10","key":"3558_CR24","first-page":"4110","volume":"6","author":"PJ Houghton","year":"2000","unstructured":"Houghton PJ, Stewart CF, Cheshire PJ, Richmond LB, Kirstein MN, Poquette CA, Tan M, Friedman HS, Brent TP (2000) Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models. Clin Cancer Res 6(10):4110\u20134118","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3558_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jmoldx.2013.08.004","volume":"16","author":"CC Pritchard","year":"2014","unstructured":"Pritchard CC, Salipante SJ, Koehler K, Smith C, Scroggins S, Wood B, Wu D, Lee MK, Dintzis S, Adey A, Liu Y, Eaton KD, Martins R, Stricker K, Margolin KA, Hoffman N, Churpek JE, Tait JF, King M-C, Walsh T (2014) Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens. J Mol Diagn 16(1):56\u201367. https:\/\/doi.org\/10.1016\/j.jmoldx.2013.08.004","journal-title":"J Mol Diagn"},{"key":"3558_CR26","doi-asserted-by":"publisher","first-page":"e00153","DOI":"10.1016\/j.plabm.2020.e00153","volume":"19","author":"AJ Kuo","year":"2020","unstructured":"Kuo AJ, Paulson VA, Hempelmann JA, Beightol M, Todhunter S, Colbert BG, Salipante SJ, Konnick EQ, Pritchard CC, Lockwood CM (2020) Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations. Pract Lab Med 19:e00153. https:\/\/doi.org\/10.1016\/j.plabm.2020.e00153","journal-title":"Pract Lab Med"},{"key":"3558_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08823-9","author":"CM Hoeman","year":"2019","unstructured":"Hoeman CM, Cordero FJ, Hu G, Misuraca K, Romero MM, Cardona HJ, Nazarian J, Hashizume R, McLendon R, Yu P, Procissi D, Gadd S, Becher OJ (2019) ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-08823-9","journal-title":"Nat Commun"},{"key":"3558_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fneur.2019.00042","volume":"10","author":"G Lu","year":"2019","unstructured":"Lu G, Rao M, Zhu P, Liang B, El-Nazer RT, Fonkem E, Bhattacharjee MB, Zhu JJ (2019) Triple-drug therapy with bevacizumab, irinotecan, and temozolomide plus tumor treating fields for recurrent glioblastoma: a retrospective study. Front Neurol 10:42. https:\/\/doi.org\/10.3389\/fneur.2019.00042","journal-title":"Front Neurol"},{"issue":"1","key":"3558_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11060-015-2008-6","volume":"127","author":"TR Hummel","year":"2016","unstructured":"Hummel TR, Salloum R, Drissi R, Kumar S, Sobo M, Goldman S, Pai A, Leach J, Lane A, Pruitt D, Sutton M, Chow LM, Grimme L, Doughman R, Backus L, Miles L, Stevenson C, Fouladi M, Dewire M (2016) A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. J Neurooncol 127(1):53\u201361. https:\/\/doi.org\/10.1007\/s11060-015-2008-6","journal-title":"J Neurooncol"},{"issue":"7","key":"3558_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3109\/08880018.2013.829895","volume":"30","author":"W Zaky","year":"2013","unstructured":"Zaky W, Wellner M, Brown RJ, Bluml S, Finlay JL, Dhall G (2013) Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab. Pediatr Hematol Oncol 30(7):623\u2013632. https:\/\/doi.org\/10.3109\/08880018.2013.829895","journal-title":"Pediatr Hematol Oncol"},{"issue":"10","key":"3558_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1200\/jco.2017.76.0611","volume":"36","author":"J Grill","year":"2018","unstructured":"Grill J, Massimino M, Bouffet E, Azizi AA, McCowage G, Ca\u00f1ete A, Saran F, Le Deley M-C, Varlet P, Morgan PS, Jaspan T, Jones C, Giangaspero F, Smith H, Garcia J, Elze MC, Rousseau RF, Abrey L, Hargrave D, Vassal G (2018) Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma. J Clin Oncol 36(10):951\u2013958. https:\/\/doi.org\/10.1200\/jco.2017.76.0611","journal-title":"J Clin Oncol"},{"issue":"3\u20134","key":"3558_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.wneu.2012.09.015","volume":"79","author":"T Yang","year":"2013","unstructured":"Yang T, Temkin N, Barber J, Geyer JR, Leary S, Browd S, Ojemann JG, Ellenbogen RG (2013) Gross total resection correlates with long-term survival in pediatric patients with glioblastoma. World Neurosurg 79(3\u20134):537\u2013544. https:\/\/doi.org\/10.1016\/j.wneu.2012.09.015","journal-title":"World Neurosurg"},{"issue":"5","key":"3558_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ccell.2018.04.004","volume":"33","author":"A Mackay","year":"2018","unstructured":"Mackay A, Burford A, Molinari V, Jones DTW, Izquierdo E, Brouwer-Visser J, Giangaspero F, Haberler C, Pietsch T, Jacques TS, Figarella-Branger D, Rodriguez D, Morgan PS, Raman P, Waanders AJ, Resnick AC, Massimino M, Garr\u00e8 ML, Smith H, Capper D, Pfister SM, W\u00fcrdinger T, Tam R, Garcia J, Thakur MD, Vassal G, Grill J, Jaspan T, Varlet P, Jones C (2018) Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial. Cancer Cell 33(5):829\u2013842.e825. https:\/\/doi.org\/10.1016\/j.ccell.2018.04.004","journal-title":"Cancer Cell"},{"issue":"3","key":"3558_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11060-014-1671-3","volume":"121","author":"R Salloum","year":"2015","unstructured":"Salloum R, Dewire M, Lane A, Goldman S, Hummel T, Chow L, Miles L, Sutton M, Stevenson C, Fouladi M, Leach J (2015) Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with bevacizumab-based therapy at diagnosis. J Neurooncol 121(3):591\u2013598. https:\/\/doi.org\/10.1007\/s11060-014-1671-3","journal-title":"J Neurooncol"},{"issue":"7","key":"3558_CR35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/MPH.0b013e318257fdac","volume":"34","author":"CM Pound","year":"2012","unstructured":"Pound CM, Clark C, Ni A, Athale U, Lewis V, Halton JM (2012) Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered trial. J Pediatr Hematol Oncol 34(7):517\u2013523. https:\/\/doi.org\/10.1097\/MPH.0b013e318257fdac","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"3558_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1586\/ecp.11.1","volume":"4","author":"J Dietrich","year":"2011","unstructured":"Dietrich J, Rao K, Pastorino S, Kesari S (2011) Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol 4(2):233\u2013242. https:\/\/doi.org\/10.1586\/ecp.11.1","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"3558_CR37","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/brain\/aww046","volume":"139","author":"KL Pitter","year":"2016","unstructured":"Pitter KL, Tamagno I, Alikhanyan K, Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M, Chan TA, Beal K, Bishop AJ, Barker CA, Jones TS, Hentschel B, Gorlia T, Schlegel U, Stupp R, Weller M, Holland EC, Hambardzumyan D (2016) Corticosteroids compromise survival in glioblastoma. Brain 139(5):1458\u20131471. https:\/\/doi.org\/10.1093\/brain\/aww046","journal-title":"Brain"},{"issue":"7","key":"3558_CR38","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/jcbfm.2015.38","volume":"35","author":"CD Hue","year":"2015","unstructured":"Hue CD, Cho FS, Cao S, Bass CRD, Meaney DF, Morrison B (2015) Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein. J Cereb Blood Flow Metab 35(7):1191\u20131198. https:\/\/doi.org\/10.1038\/jcbfm.2015.38","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03558-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-020-03558-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03558-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T23:13:33Z","timestamp":1623798813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-020-03558-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["3558"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03558-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"2 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of our institutional and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board of Seattle Children\u2019s Hospital approved this study (IRB#14449).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}